901 Inhibition of GAS6/MerTK signaling by novel MerTK antibody, 20A77, exerts significant anti-tumor efficacy with little retinal degeneration in mice

作者
Atsushi Sawada,Masayoshi Toyoura,Aki Takaiwa,Toshikazu Inoue,K. Nakamura
出处
期刊: 卷期号:: A939-A939
标识
DOI:10.1136/jitc-2022-sitc2022.0901
摘要

Background

Mer Receptor Kinase (MerTK) is a member of TAM (Tyro-3, AXL, MerTK) family of receptor tyrosine kinase and known as a macrophage receptor that mediates the efferocytosis. MerTK interacts with apoptotic cells through its ligands, Gas6 or protein S, and promotes the polarity of tumor-associated macrophages toward M2 phenotype.1 Recent studies have revealed that MerTK signaling is involved in the immune suppression in the tumor microenvironment and specific inhibition of MerTK signaling suppressed tumor progression.2-4 On the other hand, MerTK also plays an essential role in homeostasis of the retina through its ligands, Tubby and Tulp1 and the mutations in these genes cause retinal degeneration.5-9 Thus, blockage of MerTK signaling have a potential risk for the retinal toxicity.

Methods

Anti-MerTK monoclonal antibodies which recognized both with mouse and human antigen were established by immunization of recombinant human MerTK proteins in MerTK deficient mice. Isolated antibodies were analyzed their blocking activity against Gas-6 induced MerTK auto-phosphorylation by using MerTK-expressing cell-based assay. These antibodies were also analyzed their Inhibition activity of Tulp1-MerTK binding. The anti-tumor activity of isolated antibodies, 20A77 and 24A1, was evaluated in mouse colorectal CT26 bearing syngeneic mice model as monotherapy and in combination with anti-PD-1 antibody. In addition, retinal deficiency of 20A77 treated mice was analyzed histologically.

Results

The isolated antibodies, 20A77 and 24A1, specifically recognized with both mouse and human MerTK and inhibited Gas6-dependent MerTK auto phosphorylation. In contrast, these antibodies didn’t inhibit the Tulp1-MerTK binding. The treatment of either 20A77 or 24A1 antibody into CT26 bearing mice resulted in the reduction of the tumor growth. Tumor Infiltrated Lymphocyte (TIL) analysis revealed that the ratio of M1 polarized macrophage was increased in 20A77 treated mice. Moreover, the combination of anti-MerTK and anti-PD-1 antibody treatment indicated enhanced anti-tumor responses than any of single-agents of antibody treatment. Lastly, we analyzed the histological defect in the eyes of 20A77 treated mice. No deficiency of retina was detected in medical effective dose of 20A77 treated mice. However, increased amount of 20A77 treatment caused retinal degeneration.

Conclusions

Novel anti-MerTK antibody, 20A77, which selectively inhibited GAS6-mediated MerTK signaling showed significant anti-tumor activity without retinal degeneration in a mouse model. Our results suggest that the strategy for ligand-selective inhibition of MerTK signaling by the specific antibody could become a novel treatment option with lower retinal toxicity for solid tumors.

References

Zizzo G, Hilliard BA, Monestier M, Cohen PL. Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction. J Immunol. 2012;189(7):3508–3520. Zhou, et al. Blockade of the phagocytic receptor MerTK on tumor-associated macrophages enhances P2X7RDependentSTING Activation by Tumor-Derived cGAMP. Immunity. 2020;52:357–373. Lin, et al. MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression. Oncoimmunology. 2022;11: 1:e2024941 (12 pages). Davra V, Kumar S, Geng K, et al., Axl and Mertk receptors cooperate to promote breast cancer progression by combined oncogenic signaling and evasion of host antitumor immunity. Can Res. 2021;81(3):698–712. D9Cruz PM, Yasumura D, Weir J et al. Mutation of the receptor tyrosine kinase gene MERTK in the retinal dystrophic RCS rat. Hum Mol Genet. 2000;9:645–651 Gal A, Li Y, Thompson DA et al. Mutations in MERTK, the human orthologue of the RCS rat retinal dystrophy gene, cause retinitis pigmentosa. Nat Genet. 2000;26:270–271. Duncan JL, LaVail MM, Yasumura D, Yasumura D, Matthes MT et al. An RCS-like retinal dystrophy phenotype in mer knockout mice. Invest Ophthalmol vis Sci. 2003;44:826–838. Sayama A, Okado K, Nakamura K et al. UNC569-induced morphological changes in pigment epithelia and photoreceptor cells in the retina through MerTK inhibition in mice. Toxicol Pathol. 2018;46(2):193–201. Caberoy NB, Zhou Y and Li W. Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis. EMBO J. 2010;29:3898–3910.

Ethics Approval

This study was approved by the internal animal ethics board of Chiome Bioscience Inc, approval number A2018-005, A2018-015, A2019-010 and A2019-016.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
白新发布了新的文献求助10
1秒前
唠叨的莺完成签到,获得积分10
1秒前
1秒前
ZDC发布了新的文献求助10
1秒前
RachelX发布了新的文献求助10
1秒前
成就紫真发布了新的文献求助10
2秒前
阿梨完成签到,获得积分20
2秒前
彭于晏的应助被yyyt采纳,获得10
3秒前
暖柚完成签到,获得积分10
3秒前
haaaaa完成签到 ,获得积分10
4秒前
4秒前
qwa发布了新的文献求助10
5秒前
香蕉觅云的应助被Menand采纳,获得10
5秒前
5秒前
Dearth发布了新的文献求助10
5秒前
陌珩灏完成签到,获得积分10
7秒前
自信傲晴完成签到,获得积分10
7秒前
PP发布了新的文献求助10
8秒前
dddd完成签到 ,获得积分10
8秒前
8秒前
ephore的应助被活在梦中是我采纳,获得50
9秒前
张张完成签到 ,获得积分10
9秒前
极限001的应助被能能鹤采纳,获得50
10秒前
10秒前
11秒前
12秒前
wanci的应助被李白爱字由采纳,获得10
13秒前
希望天下0贩的0的应助被believe采纳,获得10
13秒前
13秒前
Dearth完成签到,获得积分10
14秒前
晗晗想吃烤鱼完成签到,获得积分10
14秒前
Yukirin完成签到,获得积分10
14秒前
缓慢藏鸟完成签到,获得积分10
14秒前
15秒前
Freya发布了新的文献求助10
16秒前
sunidea发布了新的文献求助10
16秒前
chenshi发布了新的文献求助10
16秒前
典雅翅膀发布了新的文献求助20
16秒前
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8160632
求助须知:如何正确求助?哪些是违规求助? 9555512
关于积分的说明 21728801
捐赠科研通 7750444
什么是DOI,文献DOI怎么找? 3427429
关于科研通互助平台的介绍 2552456
邀请新用户注册赠送积分活动 2471817